Masako Nakanishi, Ph.D. - Publications

2008 University of Connecticut, Storrs, CT, United States 
Genetics, Oncology

28 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Nakanishi M, Matz A, Klemashevich C, Rosenberg DW. Dietary Walnut Supplementation Alters Mucosal Metabolite Profiles During DSS-Induced Colonic Ulceration. Nutrients. 11. PMID 31137456 DOI: 10.3390/nu11051118  0.4
2018 Guan F, Tabrizian T, Novaj A, Nakanishi M, Rosenberg DW, Huffman DM. Dietary Walnuts Protect Against Obesity-Driven Intestinal Stem Cell Decline and Tumorigenesis. Frontiers in Nutrition. 5: 37. PMID 29904634 DOI: 10.3389/fnut.2018.00037  0.4
2018 Bond MJ, Bleiler M, Harrison LE, Scocchera EW, Nakanishi M, G-Dayanandan N, Keshipeddy S, Rosenberg DW, Wright DL, Giardina C. Spindle assembly disruption and cancer cell apoptosis with a CLTC-binding compound. Molecular Cancer Research : McR. PMID 29769406 DOI: 10.1158/1541-7786.MCR-18-0178  0.4
2018 Theisen E, McDougal CE, Nakanishi M, Stevenson DM, Amador-Noguez D, Rosenberg DW, Knoll LJ, Sauer JD. Cyclooxygenase-1 and -2 Play Contrasting Roles in -Stimulated Immunity. Journal of Immunology (Baltimore, Md. : 1950). PMID 29678951 DOI: 10.4049/jimmunol.1700701  0.4
2017 Nakanishi M, Hanley MP, Zha R, Igarashi Y, Hull MA, Mathias G, Sciavolino F, Grady JJ, Rosenberg DW. A novel bioactive derivative of eicosapentaenoic acid (EPA) suppresses intestinal tumor development in ApcΔ14/+ mice. Carcinogenesis. PMID 29206907 DOI: 10.1093/carcin/bgx136  0.4
2017 Chang HH, Moro A, Takakura K, Su HY, Mo A, Nakanishi M, Waldron RT, French SW, Dawson DW, Hines OJ, Li G, Go VLW, Sinnett-Smith J, Pandol SJ, Lugea A, et al. Incidence of pancreatic cancer is dramatically increased by a high fat, high calorie diet in KrasG12D mice. Plos One. 12: e0184455. PMID 28886117 DOI: 10.1371/journal.pone.0184455  0.4
2016 Nakanishi M, Chen Y, Qendro V, Miyamoto S, Weinstock E, Weinstock GM, Rosenberg DW. Effects of walnut consumption on colon carcinogenesis and microbial community structure. Cancer Prevention Research (Philadelphia, Pa.). PMID 27215566 DOI: 10.1158/1940-6207.CAPR-16-0026  0.4
2015 Giardina C, Nakanishi M, Khan A, Kuratnik A, Xu W, Brenner B, Rosenberg DW. Regulation of VDR Expression in Apc-Mutant Mice, Human Colon Cancers and Adenomas. Cancer Prevention Research (Philadelphia, Pa.). 8: 387-99. PMID 25873367 DOI: 10.1158/1940-6207.CAPR-14-0371  0.4
2015 Nakanishi M, Perret C, Meuillet EJ, Rosenberg DW. Non-cell autonomous effects of targeting inducible PGE2 synthesis during inflammation-associated colon carcinogenesis. Carcinogenesis. 36: 478-86. PMID 25634334 DOI: 10.1093/carcin/bgv004  0.36
2015 Montrose DC, Nakanishi M, Murphy RC, Zarini S, McAleer JP, Vella AT, Rosenberg DW. The role of PGE2 in intestinal inflammation and tumorigenesis. Prostaglandins & Other Lipid Mediators. 116: 26-36. PMID 25460828 DOI: 10.1016/j.prostaglandins.2014.10.002  0.4
2014 Ménoret A, Drew DA, Miyamoto S, Nakanishi M, Vella AT, Rosenberg DW. Differential proteomics identifies PDIA3 as a novel chemoprevention target in human colon cancer cells. Molecular Carcinogenesis. 53: E11-22. PMID 23255428 DOI: 10.1002/mc.21986  0.36
2013 Miyamoto S, Nakanishi M, Rosenberg DW. Suppression of colon carcinogenesis by targeting Notch signaling. Carcinogenesis. 34: 2415-23. PMID 23729655 DOI: 10.1093/carcin/bgt191  0.36
2013 Nakanishi M, Rosenberg DW. Multifaceted roles of PGE2 in inflammation and cancer. Seminars in Immunopathology. 35: 123-37. PMID 22996682 DOI: 10.1007/s00281-012-0342-8  0.4
2011 Nakanishi M, Menoret A, Tanaka T, Miyamoto S, Montrose DC, Vella AT, Rosenberg DW. Selective PGE(2) suppression inhibits colon carcinogenesis and modifies local mucosal immunity. Cancer Prevention Research (Philadelphia, Pa.). 4: 1198-208. PMID 21576350 DOI: 10.1158/1940-6207.CAPR-11-0188  0.4
2011 Amano K, Hata K, Muramatsu S, Wakabayashi M, Takigawa Y, Ono K, Nakanishi M, Takashima R, Kogo M, Matsuda A, Nishimura R, Yoneda T. Arid5a cooperates with Sox9 to stimulate chondrocyte-specific transcription. Molecular Biology of the Cell. 22: 1300-11. PMID 21346191 DOI: 10.1091/mbc.E10-07-0566  0.36
2011 Yoneda T, Hata K, Nakanishi M, Nagae M, Nagayama T, Wakabayashi H, Nishisho T, Sakurai T, Hiraga T. Involvement of acidic microenvironment in the pathophysiology of cancer-associated bone pain. Bone. 48: 100-5. PMID 20637323 DOI: 10.1016/j.bone.2010.07.009  0.36
2010 Montrose DC, Kadaveru K, Ilsley JN, Root SH, Rajan TV, Ramesh M, Nichols FC, Liang BT, Sonin D, Hand AR, Zarini S, Murphy RC, Belinsky GS, Nakanishi M, Rosenberg DW. cPLA2 is protective against COX inhibitor-induced intestinal damage. Toxicological Sciences : An Official Journal of the Society of Toxicology. 117: 122-32. PMID 20562220 DOI: 10.1093/toxsci/kfq184  0.36
2010 Nakanishi M, Gokhale V, Meuillet EJ, Rosenberg DW. mPGES-1 as a target for cancer suppression: A comprehensive invited review "Phospholipase A2 and lipid mediators". Biochimie. 92: 660-4. PMID 20159031 DOI: 10.1016/j.biochi.2010.02.006  0.36
2008 Amano K, Ichida F, Sugita A, Hata K, Wada M, Takigawa Y, Nakanishi M, Kogo M, Nishimura R, Yoneda T. MSX2 stimulates chondrocyte maturation by controlling Ihh expression. The Journal of Biological Chemistry. 283: 29513-21. PMID 18682398 DOI: 10.1074/jbc.M803681200  0.36
2008 Nakanishi M, Montrose DC, Clark P, Nambiar PR, Belinsky GS, Claffey KP, Xu D, Rosenberg DW. Genetic deletion of mPGES-1 suppresses intestinal tumorigenesis. Cancer Research. 68: 3251-9. PMID 18451151 DOI: 10.1158/0008-5472.CAN-07-6100  0.4
2007 Nakanishi M, Ménoret A, Belinsky GS, Giardina C, Godman CA, Vella AT, Rosenberg DW. Utilizing endoscopic technology to reveal real-time proteomic alterations in response to chemoprevention. Proteomics. Clinical Applications. 1: 1660-6. PMID 21136663 DOI: 10.1002/prca.200700545  0.36
2007 Flynn C, Montrose DC, Swank DL, Nakanishi M, Ilsley JN, Rosenberg DW. Deoxycholic acid promotes the growth of colonic aberrant crypt foci. Molecular Carcinogenesis. 46: 60-70. PMID 17091474 DOI: 10.1002/mc.20253  0.4
2006 Nakanishi M, Rosenberg DW. Roles of cPLA2alpha and arachidonic acid in cancer. Biochimica Et Biophysica Acta. 1761: 1335-43. PMID 17052951 DOI: 10.1016/j.bbalip.2006.09.005  0.4
2005 Ilsley JN, Nakanishi M, Flynn C, Belinsky GS, De Guise S, Adib JN, Dobrowsky RT, Bonventre JV, Rosenberg DW. Cytoplasmic phospholipase A2 deletion enhances colon tumorigenesis. Cancer Research. 65: 2636-43. PMID 15805260 DOI: 10.1158/0008-5472.CAN-04-3446  0.36
2005 Dong M, Johnson M, Rezaie A, Ilsley JNM, Nakanishi M, Sanders MM, Forouhar F, Levine J, Montrose DC, Giardina C, Rosenberg DW. Cytoplasmic phospholipase A2 levels correlate with apoptosis in human colon tumorigenesis Clinical Cancer Research. 11: 2265-2271. PMID 15788676 DOI: 10.1158/1078-0432.CCR-04-1079  0.36
2004 Nambiar PR, Nakanishi M, Gupta R, Cheung E, Firouzi A, Ma XJ, Flynn C, Dong M, Guda K, Levine J, Raja R, Achenie L, Rosenberg DW. Genetic signatures of high- and low-risk aberrant crypt foci in a mouse model of sporadic colon cancer. Cancer Research. 64: 6394-401. PMID 15374946 DOI: 10.1158/0008-5472.CAN-04-0933  0.4
2004 Dong M, Guda K, Nambiar PR, Nakanishi M, Lichtler AC, Nishikawa M, Giardina C, Rosenberg DW. Azoxymethane-induced pre-adipocyte factor 1 (Pref-1) functions as a differentiation inhibitor in colonic epithelial cells. Carcinogenesis. 25: 2239-46. PMID 15297369 DOI: 10.1093/carcin/bgh237  0.36
2004 Guda K, Upender MB, Belinsky G, Flynn C, Nakanishi M, Marino JN, Ried T, Rosenberg DW. Carcinogen-induced colon tumors in mice are chromosomally stable and are characterized by low-level microsatellite instability. Oncogene. 23: 3813-21. PMID 15021908 DOI: 10.1038/sj.onc.1207489  0.36
Show low-probability matches.